(Q51808615)

12 April 2018

title

Attenuation of experimental autoimmune myocarditis by blocking T cell activation through 4-1BB pathway. (English)

1 reference

12 April 2018

main subject

autoimmune myocarditis

1 reference

Takaaki Haga

1

1 reference

12 April 2018

Jun-Ichi Suzuki

2

1 reference

12 April 2018

Hisanori Kosuge

3

1 reference

12 April 2018

Masahito Ogawa

4

1 reference

12 April 2018

Hitoshi Saiki

5

1 reference

12 April 2018

Go Haraguchi

6

1 reference

12 April 2018

Yasuhiro Maejima

7

1 reference

12 April 2018

Mitsuaki Isobe

8

1 reference

12 April 2018

Toshimitsu Uede

9

1 reference

12 April 2018

publication date

20 February 2009

1 reference

12 April 2018

Journal of Molecular and Cellular Cardiology

published in

1 reference

12 April 2018

volume

46

1 reference

12 April 2018

issue

5

1 reference

12 April 2018

page(s)

719-727

1 reference

12 April 2018

Myocarditis and inflammatory cardiomyopathy: microbiological and molecular biological aspects

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.02.003

Cardiac autoantibodies to myosin and other heart-specific autoantigens in myocarditis and dilated cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.02.003

HMG-CoA reductase inhibitor attenuates experimental autoimmune myocarditis through inhibition of T cell activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.02.003

Control of autoimmune myocarditis and multiorgan inflammation by glucocorticoid-induced TNF receptor family-related protein(high), Foxp3-expressing CD25+ and CD25- regulatory T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.02.003

TLR ligands act directly upon T cells to restore proliferation in the absence of protein kinase C-theta signaling and promote autoimmune myocarditis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.02.003

T cell costimulation in the development of cardiac allograft vasculopathy: potential targets for therapeutic interventions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.02.003

Role of TNF receptor-associated factor 2 and p38 mitogen-activated protein kinase activation during 4-1BB-dependent immune response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.02.003

4-1BB-mediated immunotherapy of rheumatoid arthritis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.02.003

CD137 costimulatory T cell receptor engagement reverses acute disease in lupus-prone NZB x NZW F1 mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.02.003

Anti-CD137 antibodies in the treatment of autoimmune disease and cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.02.003

Co-stimulatory members of the TNFR family: keys to effective T-cell immunity?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.02.003

Blockade of the 4-1BB pathway attenuates graft arterial disease in cardiac allografts.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.02.003

Neutralizing anti-4-1BBL treatment improves cardiac function in viral myocarditis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.02.003

Expression of tumour necrosis factor (TNF) ligand superfamily co-stimulatory molecules CD30L, CD27L, OX40L, and 4-1BBL in murine hearts with acute myocarditis caused by Coxsackievirus B3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.02.003

FTY720 prevents development of experimental autoimmune myocarditis through reduction of circulating lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.02.003

cis Element decoy against nuclear factor-kappaB attenuates development of experimental autoimmune myocarditis in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.02.003

Successful gene therapy via intraarticular injection of adenovirus vector containing CTLA4IgG in a murine model of type II collagen-induced arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.02.003

Attenuation of experimental autoimmune myocarditis by blocking activated T cells through inducible costimulatory molecule pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.02.003

Serial echocardiographic assessment of left ventricular geometry and function after large myocardial infarction in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.02.003

A method to estimate cell cycle time and growth fraction using bromodeoxyuridine-flow cytometry data from a single sample

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.02.003

Dilazep, a nucleoside transporter inhibitor, modulates cell cycle progression and DNA synthesis in rat mesangial cells in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.02.003

Blockade of T cell costimulatory signals using adenovirus vectors prevents both the induction and the progression of experimental autoimmune myocarditis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.02.003

Administration of agonistic anti-4-1BB monoclonal antibody leads to the amelioration of experimental autoimmune encephalomyelitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.02.003

Resveratrol ameliorates experimental autoimmune myocarditis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.02.003

Selective regulation of tumor necrosis factor-induced Erk signaling by Src family kinases and the T cell protein tyrosine phosphatase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.02.003

NF-kappa B mediates the stimulation of cytokine and chemokine expression by human articular chondrocytes in response to fibronectin fragments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.02.003

Signal transduction by tumor necrosis factor and its relatives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.02.003

TNF-alpha induction by LPS is regulated posttranscriptionally via a Tpl2/ERK-dependent pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.02.003

IkappaB kinase is an essential component of the Tpl2 signaling pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.02.003

10.1016/J.YJMCC.2009.02.003

7 January 2021

Identifiers

DOI

1 reference

12 April 2018

PubMed ID

19233196

1 reference

12 April 2018